INS and Alzheimer disease: Besides, patients with AD may also have elevated fasting plasma insulin levels, attenuated insulin and insulin-like growth factor (IGF) receptor expression, and reduced cerebrospinal fluid (CSF)-to-plasma insulin ratio relative to healthy individuals (Steen et al., 2005).